Literature DB >> 17684701

Association of HELLP syndrome with primary antiphospholipid syndrome--a case report.

Katalin Veres1, Károly Papp, Gabriella Lakos, Edit Szomják, Zoltán Szekanecz, Gyula Szegedi, Pál Soltész.   

Abstract

Authors present the first Hungarian case of a young pregnant woman with the association of antiphospholipid syndrome (APS) and hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome. After the onset of severe preeclampsia, the pregnancy was terminated but the patient's condition continued to worsen. New symptoms of APS, including deep vein thrombosis and ischemic nervus opticus lesion, developed in the patient followed by the onset of acute respiratory distress syndrome, which required respiratory therapy. Intensive treatment with plasmapheresis, high-dose intravenous immunoglobulin, high-dose corticosteroids, cyclophosphamide, and anticoagulants eventually led to full recovery. There have been only few scattered reports in the literature on the association of HELLP syndrome and APS, which was successfully managed with the combination of various immunosuppressive and immunomodulatory treatment modalities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17684701     DOI: 10.1007/s10067-007-0687-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Catastrophic antiphospholipid syndrome: response to repeated plasmapheresis over three years.

Authors:  C M Neuwelt; D I Daikh; J A Linfoot; D A Pfister; R G Young; R L Webb; S S London; R A Asherson
Journal:  Arthritis Rheum       Date:  1997-08

Review 2.  The catastrophic antiphospholipid syndrome.

Authors:  R A Asherson
Journal:  J Rheumatol       Date:  1992-04       Impact factor: 4.666

3.  Bone marrow necrosis and refractory HELLP syndrome in a patient with catastrophic antiphospholipid antibody syndrome.

Authors:  Jayashree Sinha; Iftikhar Chowdhry; Sarah Sedan; Peter Barland
Journal:  J Rheumatol       Date:  2002-01       Impact factor: 4.666

4.  Catastrophic antiphospholipid syndrome in cancer.

Authors:  P Soltész; Z Szekanecz; J Végh; G Lakos; L Tóth; S Szakáll; K Veres; G Szegedi
Journal:  Haematologia (Budap)       Date:  2000

5.  Budd-Chiari syndrome complicating severe preeclampsia in a parturient with primary antiphospholipid syndrome.

Authors:  S Segal; S Shenhav; O Segal; E Zohav; O Gemer
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1996-09       Impact factor: 2.435

Review 6.  Antiphospholipid syndrome and thrombosis.

Authors:  R L Bick; W F Baker
Journal:  Semin Thromb Hemost       Date:  1999       Impact factor: 4.180

7.  Long-term follow-up in patients with a history of (H)ELLP syndrome.

Authors:  M G van Pampus; H Wolf; G Mayruhu; P E Treffers; O P Bleker
Journal:  Hypertens Pregnancy       Date:  2001       Impact factor: 2.108

8.  An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy; a report of 2 cases.

Authors:  M H Ornstein; J H Rand
Journal:  J Rheumatol       Date:  1994-07       Impact factor: 4.666

9.  Preeclampsia and liver infarction in early pregnancy associated with the antiphospholipid syndrome.

Authors:  O M Alsulyman; M A Castro; E Zuckerman; W McGehee; T M Goodwin
Journal:  Obstet Gynecol       Date:  1996-10       Impact factor: 7.661

10.  [Primary antiphospholipid syndrome associated with HELLP syndrome in pregnancy].

Authors:  Katalin Veres; Károly Papp; Gabriella Lakos; Edit Szomják; Gyula Szegedi; Pál Soltész
Journal:  Orv Hetil       Date:  2003-07-06       Impact factor: 0.540

View more
  2 in total

Review 1.  HELLP syndrome and its relation with the antiphospholipid syndrome.

Authors:  Antonella Tufano; Antonio Coppola; Giuseppe M Maruotti; Pasquale Martinelli; Anna M Cerbone; Giovanni Di Minno
Journal:  Blood Transfus       Date:  2013-11-15       Impact factor: 3.443

Review 2.  The significance and management of thrombocytopenia in antiphospholipid syndrome.

Authors:  Bahar Artim-Esen; Reyhan Diz-Küçükkaya; Murat İnanç
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.